Related Experiment Video

Updated: Oct 12, 2026

Electrophysiological Measurements and Analysis of Nociception in Human Infants
09:18

Electrophysiological Measurements and Analysis of Nociception in Human Infants

Published on: December 20, 2011

Developmental aspects of percutaneous caffeine absorption in premature infants

M Amato1, P Hüppi, M Isenschmid

  • 1Department of Obstetrics and Gynecology, University of Berne, Switzerland.

American Journal of Perinatology
|September 1, 1992
PubMed

Insights

Caffeine treatment for apnea of prematurity shows varying skin absorption in preterm infants. Younger infants with lower gestational age absorb more caffeine through the skin, aiding understanding of newborn skin barrier function.

Area of Science:

  • Neonatalogy
  • Pharmacokinetics
  • Dermatology

Background:

  • Caffeine is a standard treatment for apnea of prematurity.
  • Preterm infant skin maturity varies significantly, impacting drug absorption.
  • Understanding percutaneous absorption is crucial for optimizing neonatal care.

Purpose of the Study:

  • To investigate caffeine skin absorption in low birthweight infants.
  • To correlate gestational age and birthweight with caffeine absorption.
  • To enhance understanding of the neonatal skin barrier's role in drug delivery.

Main Methods:

  • Studied 56 preterm infants (gestational age 26-34 weeks, birthweight <1500 gm).
  • Administered caffeine percutaneously (7.5 mg or 10 mg twice daily based on birthweight).
  • Analyzed the relationship between infant characteristics and caffeine absorption.

Main Results:

  • Observed significant variation in skin absorption levels among preterm infants.
  • Found an inverse relationship between gestational age and caffeine skin absorption.
  • Demonstrated that percutaneous caffeine administration is a viable method for premature infants.

Conclusions:

  • Gestational age is a key factor influencing neonatal skin absorption of caffeine.
  • Results provide insights into the functional development of the newborn skin barrier.
  • Percutaneous drug administration offers a practical alternative for treating apnea of prematurity.

More Related Videos

Transcutaneous Microcirculatory Imaging in Preterm Neonates06:27

Transcutaneous Microcirculatory Imaging in Preterm Neonates

Published on: December 31, 2015

Oral Gavage in Neonatal Mouse Pups and Functional Assessment of Gut Barrier Integrity Using Ussing Chambers07:18

Oral Gavage in Neonatal Mouse Pups and Functional Assessment of Gut Barrier Integrity Using Ussing Chambers

Published on: January 9, 2026

Related Concept Videos

Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...